Murren JR - Search Results

1

Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501.

Horn L, Dahlberg SE, Sandler AB, Dowlati A, Moore DF, Murren JR, Schiller JH. Horn L, et al. Among authors: murren jr. J Clin Oncol. 2009 Dec 10;27(35):6006-11. doi: 10.1200/JCO.2009.23.7545. Epub 2009 Oct 13. J Clin Oncol. 2009. PMID: 19826110 Free PMC article. Clinical Trial.

2

Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungs.

Otterson GA, Villalona-Calero MA, Sharma S, Kris MG, Imondi A, Gerber M, White DA, Ratain MJ, Schiller JH, Sandler A, Kraut M, Mani S, Murren JR. Otterson GA, et al. Among authors: murren jr. Clin Cancer Res. 2007 Feb 15;13(4):1246-52. doi: 10.1158/1078-0432.CCR-06-1096. Clin Cancer Res. 2007. PMID: 17317836 Clinical Trial.

3

Cisplatin, doxorubicin, mitomycin C, and 5-fluorouracil for the treatment of metastatic non-small cell lung cancer. Limited activity of an aggressive chemotherapy regimen.

Murren JR, Durivage HJ, Rosenberg AH, Chen Y, Del Prete SA, Murphy GJ, Buzaid AC, Hait WN. Murren JR, et al. Am J Clin Oncol. 1994 Jun;17(3):239-41. doi: 10.1097/00000421-199406000-00012. Am J Clin Oncol. 1994. PMID: 8192110 Clinical Trial.

4

Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer.

Otterson GA, Villalona-Calero MA, Hicks W, Pan X, Ellerton JA, Gettinger SN, Murren JR. Otterson GA, et al. Among authors: murren jr. Clin Cancer Res. 2010 Apr 15;16(8):2466-73. doi: 10.1158/1078-0432.CCR-09-3015. Epub 2010 Apr 6. Clin Cancer Res. 2010. PMID: 20371682 Free PMC article. Clinical Trial.

5

High-dose cisplatin plus WR-2721 in a split course in metastatic malignant melanoma. A phase II study.

Buzaid AC, Murren J, Durivage HJ. Buzaid AC, et al. Am J Clin Oncol. 1991 Jun;14(3):203-7. Am J Clin Oncol. 1991. PMID: 1851602 Clinical Trial.

6

Perforated viscus in a patient with non-small cell lung cancer receiving bevacizumab.

Gray J, Murren J, Sharma A, Kelley S, Detterbeck F, Bepler G. Gray J, et al. J Thorac Oncol. 2007 Jun;2(6):571-3. doi: 10.1097/JTO.0b013e31805fea51. J Thorac Oncol. 2007. PMID: 17545855 Free article.

7

Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer.

Murren JR, Anderson S, Fedele J, Pizzorno G, Belliveau D, Zelterman D, Burtness BA, Tocino I, Flynn SD, Beidler D, Cheng YC. Murren JR, et al. J Clin Oncol. 1997 Jan;15(1):148-57. doi: 10.1200/JCO.1997.15.1.148. J Clin Oncol. 1997. PMID: 8996136

8

Progress in the therapy of small cell lung cancer.

Simon M, Argiris A, Murren JR. Simon M, et al. Among authors: murren jr. Crit Rev Oncol Hematol. 2004 Feb;49(2):119-33. doi: 10.1016/S1040-8428(03)00118-5. Crit Rev Oncol Hematol. 2004. PMID: 15012973 Review.

9

A phase II trial of mitomycin C, 5-fluorouracil and radiation therapy in the treatment of unresectable non-small cell lung cancer.

Murren JR, Ganpule S, Papac R, Son YH, Peschel RE, Durivage H, Buzaid AC, Lamb L, Makuch R, Hait WN. Murren JR, et al. Oncol Res. 1993;5(2):53-7. Oncol Res. 1993. PMID: 8395915 Clinical Trial.

10

Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer.

Burtness B, Gibson M, Egleston B, Mehra R, Thomas L, Sipples R, Quintanilla M, Lacy J, Watkins S, Murren JR, Forastiere AA. Burtness B, et al. Among authors: murren jr. Ann Oncol. 2009 Jul;20(7):1242-8. doi: 10.1093/annonc/mdn787. Epub 2009 May 8. Ann Oncol. 2009. PMID: 19429872 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page